Rationale for treating cancer with somatostatin analogs

J Endocrinol Invest. 2003;26(8 Suppl):117-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Cell Cycle / drug effects
  • Humans
  • Mitosis / drug effects
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Receptors, Somatostatin / classification
  • Receptors, Somatostatin / drug effects
  • Receptors, Somatostatin / metabolism*
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Receptors, Somatostatin
  • Somatostatin